Equity in Access Research Grant - Building Evidence for Effective Interventions to Increase Therapeutic Cancer Clinical Trial Accrual: Promoting Access for Patients from Underrepresented Groups

To fund research studies that will increase our understanding of effective interventions for increasing accrual to therapeutic cancer clinical trials, particularly among underrepresented populations. Specifically, we seek proposals that will implement and evaluate interventions designed to a) mitigate multilevel barriers to therapeutic clinical trial accrual for underrepresented groups and b) quantitatively measure the impact of these interventions on patient accrual. We are particularly interested in proposals that address systemic, institutional, and clinician-related barriers that impede clinical trial participation.

Funding available up to $500,000 per year for up five years.

The application process will occur in two phases: Letter of Intent (LOI) and Full Application. Both the LOI and the Full Application must be submitted electronically to the LLS Research Portal. 

Results Announced: Spring 2025

Information Webinar, June 18, 2024, 12:00 1:00 p.m. EST: Click here to register